Skip to main content
Premium Trial:

Request an Annual Quote

Where Are They Now?: Jun 1, 2003

Premium

A year ago, GT reached you with its “Mass Spec Special” cover story. We looked at the instruments available and used feedback from a reader survey to help break down which mass spec was right for which type of user. A year later, the mass spec field continues to heat up. As our cover story in this issue shows, Fourier transform mass spec is becoming the latest trend, and hybrid instruments are rising up as well. (See p. 34)

We also looked at the DNA sequencer scandal last year — the lawsuit launched by MJ Research against Applied Biosystems and others had just been unsealed. Since then, the lawsuit has moved forward, although filings of motions have considerably slowed the pace at which it was originally estimated to take place. We also reported in the April ’03 issue that Henry Huang, whom MJ Research claims actually invented the four-color DNA sequencer, filed his own lawsuit against ABI and the patent owners.

Last June, GT checked in on Bruce Roe, head of the University of Oklahoma’s genome center. Roe’s lab expects to move as soon as this coming academic year into the brand new Peggy and Charles Stephenson Research and Technology Center, built for genomics and computer science, among other technology-based disciplines.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.